The sell-off that decimated Markel's stock trading premium after the US specialty insurer's proposed takeover of Alterra was announced appears a strong indication of investor displeasure.
The sell-off that decimated Markel's stock trading premium after the US specialty insurer's proposed takeover of Alterra was announced appears a strong indication of investor displeasure.